Fully deleted adenovirus vectors (FD-AdVs) would appear to be promising tools for gene therapy. Since these vectors are deleted of all adenoviral genes, they require a helper adenovirus for their ...
Researchers have developed a new and improved viral vector -- a virus-based vehicle that delivers therapeutic genes -- for use in gene therapy for sickle cell disease. In advanced lab tests using ...
There is currently an urgent need to develop efficient gene-delivery systems for the lung that are free of inflammatory effects. The LID vector is a synthetic gene delivery system, comprised of ...
A radically redesigned viral vector may improve the delivery of therapeutic genes to patients with sickle-cell disease. According to tests in animal models, the new vector is up to ten times more ...
Researchers at the National Institutes of Health (NIH) have developed a unique, improved viral vector to use in gene therapy for sickle cell disease. Using animal models, the new vector was shown to ...
Manufacturers must address scale-out challenges of autologous cell therapy for commercial manufacturing. Although only a few cell-therapy treatments have regulatory approval, recent years have seen a ...
Researchers at the National Institutes of Health (NIH) have developed a new and improved viral vector--a virus-based vehicle that delivers therapeutic genes--for use in gene therapy for sickle cell ...
A novel and improved viral vector for use in gene therapy in sickle cell disease has been developed by National Institutes of Health (NIH) researchers. In advanced lab tests using animal models, the ...
Researchers at the National Institutes of Health have developed a new and improved viral vector a virus-based vehicle that delivers therapeutic genes for use in gene therapy for sickle cell disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback